Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
Bioavailability |
26.0 |
% |
26±18 |
% |
PO, oral; Male, men; adults; normal,healthy; extensive metabolizers, EM; |
|
The Pharmacological Basis of Therapeutics |
Bioavailability |
91.0 |
% |
91±40 |
% |
PO, oral; Male, men; adults; normal,healthy; poor metabolizers, PM; |
|
The Pharmacological Basis of Therapeutics |
C Max |
5.2 |
ng/ml |
5.2±5.7 |
ng/ml |
PO, oral; Male, men; adults; normal,healthy; extensive metabolizers, EM; |
|
The Pharmacological Basis of Therapeutics |
C Max |
38.0 |
ng/ml |
38±15 |
ng/ml |
PO, oral; Male, men; adults; normal,healthy; poor metabolizers, PM; |
|
The Pharmacological Basis of Therapeutics |
T Max |
1.2 |
h |
1.2±0.5 |
h |
PO, oral; Male, men; adults; normal,healthy; extensive metabolizers, EM; |
|
The Pharmacological Basis of Therapeutics |
T Max |
1.9 |
h |
1.9±1.0 |
h |
PO, oral; Male, men; adults; normal,healthy; poor metabolizers, PM; |
|
The Pharmacological Basis of Therapeutics |
Clearance |
0.58 |
L/h/kg |
9.6±2.8 |
ml/min/kg |
extensive metabolizers, EM; normal,healthy; adults; Male, men; |
|
The Pharmacological Basis of Therapeutics |
Clearance |
0.12 |
L/h/kg |
2.0±0.3 |
ml/min/kg |
poor metabolizers, PM; normal,healthy; adults; Male, men; |
hepatopathy,LD ↓ ; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.50 |
L/h/kg |
8.4 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
113.0 |
L |
113 ± 26.7 |
L |
|
|
DRUGBANK |
Volume of Distribution |
1.7 |
L/kg |
1.7±0.4 |
L/kg |
extensive metabolizers, EM; normal,healthy; adults; Male, men; |
|
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
1.5 |
L/kg |
1.5±0.4 |
L/kg |
poor metabolizers, PM; normal,healthy; adults; Male, men; |
|
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
1.5 |
L/kg |
1.5 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
2.8 |
h |
1.9-3.7 |
h |
|
|
DRUGBANK |
Half-life |
2.3 |
h |
2.3±0.3 |
h |
extensive metabolizers, EM; normal,healthy; adults; Male, men; |
chronic liver disease ↑ ; |
The Pharmacological Basis of Therapeutics |
Half-life |
9.2 |
h |
9.2±1.2 |
h |
poor metabolizers, PM; normal,healthy; adults; Male, men; |
chronic liver disease ↑ ; |
The Pharmacological Basis of Therapeutics |
Half-life |
2.4 |
h |
2.4 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
77.0 |
% |
77 |
% |
Urinary excretion; PO, oral; normal,healthy; human, homo sapiens; |
|
DRUGBANK |
Eliminate Route |
17.0 |
% |
17 |
% |
Faeces excretion; PO, oral; normal,healthy; human, homo sapiens; |
|
DRUGBANK |
Eliminate Route |
0 |
% |
~0 |
% |
Urinary excretion; adults; Male, men; normal,healthy; extensive metabolizers, EM; human, homo sapiens; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Eliminate Route |
2.5 |
% |
<2.5 |
% |
Urinary excretion; adults; Male, men; normal,healthy; poor metabolizers, PM; human, homo sapiens; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
96.3 |
% |
~96.3 |
% |
|
|
DRUGBANK |
Protein Binding |
96.3 |
% |
96.3 |
% |
adults; Male, men; normal,healthy; human, homo sapiens; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
64.0 |
% |
64 |
% |
Active metabolite; adults; Male, men; normal,healthy; human, homo sapiens; |
|
The Pharmacological Basis of Therapeutics |